EU Gilead
Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19
June 26, 2020Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir
In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
